Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The human pregnancy-specific glycoproteins (PSGs) are a group of molecules that are mainly produced by the placental syncytiotrophoblasts during pregnancy. Additionally we are shipping PSG9 Proteins (4) and PSG9 Kits (1) and many more products for this protein.
Showing 10 out of 60 products:
Results indicate that pregnancy-specific glycoprotein 9 (PSG9 (show PSG4 Antibodies)) may facilitate the development of hepatocellular carcinoma (HCC (show FAM126A Antibodies)) by fostering angiogenesis via promoting VEGFA (show VEGFA Antibodies) production in cancer HCC (show FAM126A Antibodies).
Findings illustrate the innovative mechanism by which PSG9 (show PSG4 Antibodies) drives the progression of colorectal cancer and tumor angiogenesis. This occurs via nuclear translocation of PSG9 (show PSG4 Antibodies)/SMAD4 (show SMAD4 Antibodies), which activates angiogenic cytokines.
PSG9 (show PSG4 Antibodies), through its activation of TGFbeta (show TGFB1 Antibodies)-1, could be a potent inducer of immune tolerance
PSG9 (show PSG4 Antibodies) may have a role in development of colorectal carcinogenesis in patients with adenomatous polyposis coli (show APC Antibodies)
The human pregnancy-specific glycoproteins (PSGs) are a group of molecules that are mainly produced by the placental syncytiotrophoblasts during pregnancy. PSGs comprise a subgroup of the carcinoembryonic antigen (CEA) family, which belongs to the immunoglobulin superfamily. For additional general information about the PSG gene family, see PSG1 (MIM 176390).
pregnancy-specific beta-1-glycoprotein 9
, pregnancy-specific beta-1 glycoprotein B
, pregnancy specific beta-1-glycoprotein 11